NCT01992289 - Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

X-linked Hypohidrotic Ectodermal Dysplasia

Interventions

DRUG

EDI200

Long-term follow-up study of subjects that received EDI200 as part of protocol ECP-002

Trial Locations (7)

Children's National Medical Center, Washington D.C.

"Azienda Ospedaliera-Polo Universitario Luigi Sacco", Milan

Washington University School of Medicine, St Louis

Hôpital Necker-Enfants Malades, Paris

Universitätsklinikum Erlangen, Erlangen

University of California, San Francisco, San Francisco

University Hospital of Wales, Cardiff